David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.09% |
| 2 | Technology | 17.04% |
| 3 | Healthcare | 13.44% |
| 4 | Consumer Discretionary | 13.38% |
| 5 | Financials | 7.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
AerCap
AER
$23.2B
| $1.88M | ﹤0.01% |
40,411
-49,191
| -55% | -$2.22M |
|
|
DNKN
2152
CALL
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $1.88M | ﹤0.01% |
25,000
+10,000
| +67% | +$700K |
|
|
PLYA
2153
DELISTED
Playa Hotels & Resorts
PLYA
| $1.87M | ﹤0.01% |
245,580
+7,528
| +3% | +$58.3K |
|
2154
Forward Air
FWRD
$594M
| $1.87M | ﹤0.01% |
28,851
+18,371
| +175% | +$1.12M |
|
2155
Pampa Energía
PAM
$4.38B
| $1.87M | ﹤0.01% |
+67,703
| New | +$2.27M |
|
2156
Hilton Worldwide
HLT
$73.5B
| $1.86M | ﹤0.01% |
22,445
-107,989
| -83% | -$8.45M |
|
2157
NWPX Infrastructure Inc
NWPX
$1.09B
| $1.86M | ﹤0.01% |
77,598
-24,981
| -24% | -$592K |
|
2158
PUT
Kimberly-Clark
KMB
$36.5B
| $1.86M | ﹤0.01% |
15,000
| – | – |
|
2159
Intuitive Surgical
ISRG
$130B
| $1.86M | ﹤0.01% |
9,759
-55,650
| -85% | -$9.89M |
|
2160
Fortuna Silver Mines
FSM
$3.78B
| $1.85M | ﹤0.01% |
555,799
-163,800
| -23% | -$606K |
|
2161
AudioCodes
AUDC
$246M
| $1.85M | ﹤0.01% |
133,594
+121,383
| +994% | +$1.6M |
|
2162
Allegiant Air
ALGT
$2.24B
| $1.85M | ﹤0.01% |
14,273
-49,391
| -78% | -$6.28M |
|
2163
Rockwell Medical
RMTI
$31.6M
| $1.83M | ﹤0.01% |
2,929
+1,715
| +141% | +$782K |
|
|
NTUS
2164
DELISTED
Natus Medical Inc
NTUS
| $1.83M | ﹤0.01% |
+72,147
| New | +$2.15M |
|
2165
Apogee Enterprises
APOG
$856M
| $1.83M | ﹤0.01% |
48,806
+41,536
| +571% | +$1.44M |
|
2166
CALL
Lowe's Companies
LOW
$116B
| $1.83M | ﹤0.01% |
16,700
-87,500
| -84% | -$8.73M |
|
|
UNT
2167
DELISTED
UNIT Corporation
UNT
| $1.83M | ﹤0.01% |
128,378
+77,226
| +151% | +$1.23M |
|
2168
PUT
APA Corp
APA
$14.8B
| $1.83M | ﹤0.01% |
52,700
-9,100
| -15% | -$297K |
|
|
RHT
2169
PUT
DELISTED
Red Hat Inc
RHT
| $1.83M | ﹤0.01% |
10,000
-35,900
| -78% | -$6.44M |
|
2170
PUT
Sarepta Therapeutics
SRPT
$2.34B
| $1.82M | ﹤0.01% |
15,300
-20,000
| -57% | -$2.57M |
|
2171
CALL
Parker-Hannifin
PH
$128B
| $1.82M | ﹤0.01% |
10,600
-59,900
| -85% | -$9.93M |
|
2172
PUT
Molson Coors Class B
TAP
$7.8B
| $1.82M | ﹤0.01% |
30,500
| – | – |
|
2173
CALL
HSBC
HSBC
$352B
| $1.82M | ﹤0.01% |
45,333
+14,217
| +46% | +$573K |
|
2174
Covenant Logistics
CVLG
$915M
| $1.82M | ﹤0.01% |
191,438
+56,546
| +42% | +$626K |
|
|
AVID
2175
DELISTED
Avid Technology Inc
AVID
| $1.81M | ﹤0.01% |
243,201
+191,577
| +371% | +$994K |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $2.66B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.